Fresenius Medical Care AG & Co. KGaAFMSNYSE
Loading
Cost of Revenue Over TimeStable
Percentile Rank100
3Y CAGR+0.2%
5Y CAGR+3.4%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+0.2%/yr
vs +6.2%/yr prior
5Y CAGR
+3.4%/yr
Recent deceleration
Acceleration
-6.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
7 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$14.60B+0.1%
2024$14.58B+0.3%
2023$14.53B+0.2%
2022$14.50B+12.9%
2021$12.85B+4.3%
2020$12.32B+2.0%
2019$12.08B+6.0%
2018$11.39B-3.3%
2017$11.78B+2.1%
2016$11.53B-